184 related articles for article (PubMed ID: 24050965)
1. Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus.
Teixeira RA; Borba EF; Pedrosa A; Nishioka S; Viana VS; Ramires JA; Kalil-Filho R; Bonfá E; Martinelli Filho M
Europace; 2014 Jun; 16(6):887-92. PubMed ID: 24050965
[TBL] [Abstract][Full Text] [Related]
2. [Disorders of conduction in lupus erythematosus : frequency and incidence in a group of 112 patients (author's transl)].
Godeau P; Guillevin L; Fechner J; Bletry O; Herreman G
Ann Med Interne (Paris); 1981; 132(4):234-40. PubMed ID: 7305172
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmias in systemic lupus erythematosus.
Teixeira RA; Borba EF; Bonfá E; Martinelli Filho M
Rev Bras Reumatol; 2010; 50(1):81-9. PubMed ID: 21125143
[TBL] [Abstract][Full Text] [Related]
4. Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort.
Bourré-Tessier J; Urowitz MB; Clarke AE; Bernatsky S; Krantz MJ; Huynh T; Joseph L; Belisle P; Bae SC; Hanly JG; Wallace DJ; Gordon C; Isenberg D; Rahman A; Gladman DD; Fortin PR; Merrill JT; Romero-Diaz J; Sanchez-Guerrero J; Fessler B; Alarcón GS; Steinsson K; Bruce IN; Ginzler E; Dooley MA; Nived O; Sturfelt G; Kalunian K; Ramos-Casals M; Petri M; Zoma A; Pineau CA
Arthritis Care Res (Hoboken); 2015 Jan; 67(1):128-35. PubMed ID: 24838943
[TBL] [Abstract][Full Text] [Related]
5. Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus.
McGhie TK; Harvey P; Su J; Anderson N; Tomlinson G; Touma Z
Clin Exp Rheumatol; 2018; 36(4):545-551. PubMed ID: 29652656
[TBL] [Abstract][Full Text] [Related]
6. The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters.
Wozniacka A; Cygankiewicz I; Chudzik M; Sysa-Jedrzejowska A; Wranicz JK
Lupus; 2006; 15(8):521-5. PubMed ID: 16942005
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.
Islam MN; Hossain M; Haq SA; Alam MN; Ten Klooster PM; Rasker JJ
Int J Rheum Dis; 2012 Feb; 15(1):62-8. PubMed ID: 22324948
[TBL] [Abstract][Full Text] [Related]
8. Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases.
Costedoat-Chalumeau N; Hulot JS; Amoura Z; Leroux G; Lechat P; Funck-Brentano C; Piette JC
Rheumatology (Oxford); 2007 May; 46(5):808-10. PubMed ID: 17202178
[TBL] [Abstract][Full Text] [Related]
9. QT interval parameters, anti-Ro antibody status, and disease activity in systemic lupus erythematosus.
Azharudeen M; Thabah MM; Satheesh S; Negi VS
J R Coll Physicians Edinb; 2020 Dec; 50(4):380-386. PubMed ID: 33469612
[TBL] [Abstract][Full Text] [Related]
10. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
[TBL] [Abstract][Full Text] [Related]
11. Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus.
Bourré-Tessier J; Clarke AE; Huynh T; Bernatsky S; Joseph L; Belisle P; Pineau CA
Arthritis Care Res (Hoboken); 2011 Jul; 63(7):1031-7. PubMed ID: 21452253
[TBL] [Abstract][Full Text] [Related]
12. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
Campos LM; Silva CA; Aikawa NE; Jesus AA; Moraes JC; Miraglia J; Ishida MA; Bueno C; Pereira RM; Bonfa E
Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1121-7. PubMed ID: 23818263
[TBL] [Abstract][Full Text] [Related]
13. Predicting Sjögren's syndrome in patients with recent-onset SLE.
Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
[TBL] [Abstract][Full Text] [Related]
14. The effect of atropine on rhythm and conduction disturbances during 322 critical care intubations.
Jones P; Dauger S; Denjoy I; Pinto da Costa N; Alberti C; Boulkedid R; Peters MJ
Pediatr Crit Care Med; 2013 Jul; 14(6):e289-97. PubMed ID: 23689705
[TBL] [Abstract][Full Text] [Related]
15. Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease.
Lazzerini PE; Capecchi PL; Guideri F; Bellisai F; Selvi E; Acampa M; Costa A; Maggio R; Garcia-Gonzalez E; Bisogno S; Morozzi G; Galeazzi M; Laghi-Pasini F
Am J Cardiol; 2007 Sep; 100(6):1029-34. PubMed ID: 17826392
[TBL] [Abstract][Full Text] [Related]
16. Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
Lesiak A; Narbutt J; Sysa-Jedrzejowska A; Lukamowicz J; McCauliffe DP; Wózniacka A
Lupus; 2010 May; 19(6):683-8. PubMed ID: 20064914
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study.
Lalani S; Pope J; de Leon F; Peschken C;
J Rheumatol; 2010 Jan; 37(1):38-44. PubMed ID: 20008925
[TBL] [Abstract][Full Text] [Related]
18. Absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: a multicenter study of 689 patients.
Massie C; Hudson M; Tatibouet S; Steele R; Huynh T; Fritzler MJ; Baron M; Pineau CA;
Semin Arthritis Rheum; 2014 Dec; 44(3):338-44. PubMed ID: 25128430
[TBL] [Abstract][Full Text] [Related]
19. Comparison of non-invasive assessment of arrhythmias, conduction disturbances and cardiac autonomic tone in systemic sclerosis and systemic lupus erythematosus.
Bienias P; Ciurzyński M; Kisiel B; Chrzanowska A; Ciesielska K; Siwicka M; Kalińska-Bienias A; Saracyn M; Lisicka M; Radochońska J; Pruszczyk P
Rheumatol Int; 2019 Feb; 39(2):301-310. PubMed ID: 30421103
[TBL] [Abstract][Full Text] [Related]
20. [Chloroquine cardiotoxicity in long-term lupus therapy in two patients].
Saussine A; Loriot MA; Picard C; Lecerf V; Landry J; Scheer I; Voicu S; Leenhardt A; Ducrocq G; Maubec E; Crickx B
Ann Dermatol Venereol; 2009; 136(6-7):530-5. PubMed ID: 19560616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
